Multimodality optical imaging and18F-FDG uptake in wild-type p53-containing and p53-null human colon tumor xenografts

Cancer Biology and Therapy

Volumn 6, Issue 10, 2007, Pages 1649-1653

  Wang, Shulin ^a   Mintz, Akiva ^a   Mochizuki, Kenjiro ^a   Dorsey, Jay F ^a   Ackermann, Joseph M ^a   Alavi, Abass ^a   El Deiry, Wafik S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bioluminescence imaging; Cancer; FDG PET imaging; Fluorescence imaging; Glycolytic metabolism; p53; PET CT; Warburg effect

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GREEN FLUORESCENT PROTEIN; HEXOKINASE; HYPOXIA INDUCIBLE FACTOR 1; MYC PROTEIN; PROTEIN KINASE B; PROTEIN P53; RED FLUORESCENT PROTEIN; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER CELL; CARCINOGENESIS; CELL SURVIVAL; COLON TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GENE INDUCTION; GENE REGULATORY NETWORK; GENE SILENCING; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; IMAGING; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; NORTHERN BLOTTING; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WILD TYPE; XENOGRAFT; ANIMAL; DRUG ANTAGONISM; DRUG SCREENING; GENETICS; METABOLISM; PHYSIOLOGY;

AEROBIOSIS; ANIMALS; COLONIC NEOPLASMS; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLYCOLYSIS; HUMANS; MICE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 41649093438     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.10.4948     Document Type: Article

References (13)